secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2026-08-21T21:25:19+00:00
Accession:  0001079973-26-001169
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Starling Oncology signs $25M revolver with SLR Healthcare ABL; $4.75M drawn at close
--------------------------------------------------------------------------------

- Credit agreement dated Aug 20, 2026; facility up to $25M, secured by substantially all SOM, LLC collateral.
- $4.75M outstanding as of Aug 21, 2026 closing date; proceeds for working capital and general corporate purposes.
- Maturity Aug 20, 2029; interest at Term SOFR (floor 2.00%) plus 3.95%, default rate adds 5.00%.
- Borrowing base formula on receivables; covenants cap Maximum Loan Turn Days at 35 on rolling 3-month basis.
- Fees include collateral monitoring 0.0833%/mo, unused line 0.04166%/mo, and termination fees up to 3%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326001169/0001079973-26-001169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326001169/stln_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-001169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer